Lysyl Oxidases Play a Causal Role in Vascular Remodeling in Clinical and Experimental Pulmonary Arterial Hypertension
Alexander H. Nave(Universität Hamburg), Rory E. Morty(Heidelberg University), Werner Seeger(Justus-Liebig-Universität Gießen), Susanne Herold(Justus-Liebig-Universität Gießen), István Vadász(Northwestern University), María L. Talavera, Konstantin Mayer(Chemisches und Veterinäruntersuchungsamt Karlsruhe), Jürgen Brinckmann(University of Lübeck), Norbert Weißmann(Cardio-Pulmonary Institute), Frank Reichenberger, Ivana Mižíková(Max Planck Institute for Heart and Lung Research), Heiko Steenbock(University of Lübeck), Gero Niess(Max Planck Institute for Heart and Lung Research), Florian Veit(University of Freiburg)
Cited by 120
Related Papers
ESPEN guideline on clinical nutrition in the intensive care unit
|Clinical Nutrition|2018|2.8k
Clinical classification of pulmonary hypertension
|Journal of the American College of Cardiology|2004|1.9k
Inhaled Iloprost for Severe Pulmonary Hypertension
|New England Journal of Medicine|2002|1.8k
Pulmonary hypertension in chronic lung disease and hypoxia
|European Respiratory Journal|2018|777